Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively inhibits monoamine oxidase type B (MAO-B). Rasagiline demonstrates complete and selective ...

As a selective monoamine oxidase B (MAO-B) inhibitor, XADAGO offers a unique mechanism of action that complements traditional therapies, potentially improving motor function and reducing "off ...

Announcing a new publication for Acta Materia Medica journal. Monoamine oxidase (MAO) is a useful target in the treatment of neurodegenerative diseases and depressive disorders. Understanding the ...

Sumatriptan and others are contraindicated in patients taking monoamine oxidase (MAO) inhibitors or within 2 weeks of stopping one. They are deemed pregnancy category C (risk cannot be ruled out).

On the latest edition of the JRE Fight Companion, Joe Rogan spoke to his close friend, ex-UFC heavyweight Brendan Schaub about his use of monoamine oxidase ... it's basically an MAO inhibitor ...

On episode #2304 of The Joe Rogan Experience, the popular podcaster welcomed controversial biologist Gary Brecka.

Healthcare providers may prescribe levodopa, dopamine agonists, anticholinergics, catechol-o-methyltransferase (COMT) inhibitors, and type-B monoamine oxidase (MAO-B) inhibitors to manage symptoms.

a MAO-B = monoamine oxidase type B, MAO-A = monoamine oxidase type A. b Expressed as the molar concentration of drug required to inhibit enzyme activity by 50% (nmol/L). c Expressed as the ...

DelveInsight's "XADAGO/EQUFINA Market Size, Forecast, and Market Insight Report" highlights the details around XADAGO/EQUFINA ...